A new study supports the theory that chronic fatigue syndrome is an autoimmune disease, offering patients with the controversial condition new hope for a cure.
Two injections of the cancer drug Rituximab, which suppresses the immune system, relieved chronic fatigue symptoms in 10 of 15 patients several months later, according to a small Norwegian clinical trial.
The drug works by depleting the body's B-cells, lymphocytes that release antibodies important for fighting infections. It has also...
Full Story